Recommendations for the Verification of Quantitative Molecular Hemato-Oncology Tests

다국어 초록 (Multilingual Abstract)

Quantitative molecular genetic tests are increasingly used for the detection and quantification of target molecules or genetic alterations. When introducing a new assay into clinical laboratories, it is necessary to verify the manufacturers’ claimed performance characteristics within individual laboratories. Appropriate assay verification procedures are essential to ensure the quality of test results in clinical laboratories. This study aimed to provide recommendations for the verification of quantitative molecular genetic testing focused on the hemato-oncology field in clinical genetic laboratories. Based on a literature review, we provide recommendations for the performance verification of quantitative molecular hemato-oncology tests. The performance characteristic elements that comprise the verification procedures are presented and exemplified. These recommendations can assist individual clinical laboratories in verifying quantitative molecular diagnostic assays

참고문헌 (Reference)

1 Clinical and Laboratory Standards Institute, "User veriflcation of precision and estimation of bias; Approved guideline—Third edition" Clinical and Laboratory Standards Institute 2014

2 Halling KC, "Test veriflcation and validation for molecular diagnostic assays" 136 : 11-13, 2012

3 "Standard: Establishment and veriflcation of performance speciflcations. 42 CFR § 493.1253, Oct. 1, 2015"

4 Jennings L, "Recommended principles and practices for validating clinical molecular pathology tests" 133 : 743-755, 2009

5 BIO-RAD, "Rare Mutation Detection Best Practices Guidelines"

6 Clinical and Laboratory Standards Institute, "Quality management for molecular genetic testing; Approved guideline" Clinical and Laboratory Standards Institute 2012

7 Hee-Jung Chung ; 허미나 ; Sumi Yoon ; Keumrock Hwang ; Hwan-Sub Lim ; Hanah Kim ; Hee-Won Moon ; Yeo-Min Yun, "Performance Evaluation of the QXDx BCR-ABL %IS Droplet Digital PCR Assay" 대한진단검사의학회 40 (40): 72-75, 2020

8 College of American Pathologists, "Molecular pathology checklist" College of American Pathologists 2021

9 Clinical and Laboratory Standards Institute, "Molecular methods for clinical genetics and oncology testing; Approved guideline—Third edition" Clinical and Laboratory Standards Institute 2012

10 Association for Molecular Pathology, "Molecular Diagnostic Assay Validation : Update to the 2009 AMP Molecular Diagnostic Assay Validation White Paper"

11 Shrivastava A, "Methods for the determination of limit of detection and limit of quantitation of the analytical methods" 2 : 21-25, 2011

12 Armbruster DA, "Limit of blank, limit of detection and limit of quantitation" 29 (29): S49-S52, 2008

13 Broeders S, "Guidelines for validation of qualitative real-time PCR methods" 37 : 115-126, 2014

14 Clinical and Laboratory Standards Institute, "Evaluation of linearity of quantitative measurement procedures" Clinical and Laboratory Standards Institute 2020

15 Clinical and Laboratory Standards Institute, "Evaluation of detection capability for clinical laboratory measurement procedures; Approved guideline—Second edition" Clinical and Laboratory Standards Institute 2012

16 Yuan D, "Droplet digital PCR for quantiflcation of PML-RARα in acute promyelocytic leukemia : a comprehensive comparison with real-time PCR" 411 : 895-903, 2019

17 Mazaika E, "Digital droplet PCR : CNV analysis and other applications" 82 : 7.24.1-7.24.13, 2014

18 Wolstencroft EC, "Development of a quantitative real-time polymerase chain reaction assay for the detection of the JAK2 V617F mutation" 9 : 42-46, 2007

19 Schnittger S, "Development and validation of a real-time quantiflcation assay to detect and monitor BRAFV600E mutations in hairy cell leukemia" 119 : 3151-3154, 2012

20 Jennings LJ, "Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease" 136 : 33-40, 2012

21 Clinical and Laboratory Standards Institute, "Deflning, establishing, and verifying reference intervals in the clinical laboratory; Approved guideline—3rd edition" Clinical and Laboratory Standards Institute 2010

22 Mattocks CJ, "A standardized framework for the validation and veriflcation of clinical molecular genetic tests" 18 : 1276-1288, 2010

23 Heuser M, "2021 Update on MRD in acute myeloid leukemia : a consensus document from the European LeukemiaNet MRD Working Party" 138 : 2753-2767, 2021